#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyoderma gangrenosum Bronchopulmonary aspergillosis Pseudoxanthoma elasticum Amyotrophic lateral sclerosis Red blood cell abnormality Myotonia Indolent systemic mastocytosis Leiomyosarcoma recurrent Malignant central nervous system neoplasm Neuroblastoma recurrent Rosai-Dorfman syndrome Choroid melanoma Chordoma Adenomatous polyposis coli Head and neck cancer More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Mastocytosis – Diagnostics Chondrosarcoma metastatic – Treatment Familial haemophagocytic lymphohistiocytosis Mast cell activation syndrome Splenic marginal zone lymphoma – Basic Information Breast angiosarcoma metastatic – Basic Information Brain stem glioma – Treatment Testicular leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tebentafusp LY3537021 Bay 3018250 Acemetacin GSKVX000000025896 Venetoclax DCC-3084 Mps-200 Lasmiditan Air, Medicinal LY4170156 Dapagliflozin Propanediol Mirikizumab Magnesium Oxide, Light JNJ-75276617 Aptamer-4Ft Io103 Acetate HYDROMORPHONE HYDROCHLORIDE M1P Dipotassium Salt Art6043 More therapies…

    Learn about Your Condition

    Colon cancer metastatic Encephalitis autoimmune Neoplasm Osteomyelitis acute Psychotic disorder Breast cancer stage III Microscopic polyangiitis Cystic fibrosis Anal abscess Pre-eclampsia Pneumothorax Lung transplant rejection Cardiac amyloidosis Precocious puberty Lennox-Gastaut syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Erythromycin and Neomycin for Preventing Infections After Colorectal Surgery in Patients Undergoing Elective Procedures

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Postoperative wound infection
    Investigated Drugs:
    • Erythromycin
    Ireland

  • Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Benign neoplasm of thyroid gland
    • Hyperthyroidism
    • Primary hyperthyroidism
    Investigated Drugs:
    • Sodium Iodide (131I)
    The Netherlands

  • Study on Long-Term Kidney Transplant Outcomes in Low-Risk Patients Using Tacrolimus Alone or with Mycophenolate Mofetil

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 17F
    • Pneumococcal Polysaccharide Serotype 2
    • Pneumococcal Polysaccharide Serotype 20
    The Netherlands

  • Study on the Effects of (+)-α-Dihydrotetrabenazine for Treating Tardive Dyskinesia in Patients with Schizophrenia, Mood, or Gastrointestinal Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Tardive dyskinesia
    Investigated Drugs:
    • (2R,3R,11Br)-1,3,4,6,7,11B-Hexahydro-9,10-Dimethoxy-3-(2-Methylpropyl)-2H-Benzo[A]Quinolizin-2-Ol
    Croatia

  • Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Staphylococcal infection
    • Medical device site joint infection
    Investigated Drugs:
    • Pp1493
    • Pp1815
    • Sodium Chloride
    France The Netherlands Spain

  • Study of L19TNF (onfekafusp alfa) with temozolomide chemoradiotherapy for newly diagnosed glioblastoma patients

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Onfekafusp Alfa
    • Temozolomide
    Germany Italy
Previous Page
1 … 808 809 810 811 812 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!